Iridium Continuing Education at CMEpalooza: Conundrums in CME: Be the Jury

APEX, NORTH CAROLINA, UNITEDSTATES, March 17, 2023/ -- CMEpalooza is a free, online educational program heldtwice per year and marketed with thetagline “where the CME/CE communityhangs out.” It’s a place where those inthe continuing medical education fieldoften engage in innovative, creativesessions.

Melissa Wiles, President of IridiumContinuing Education is tasked withrepresenting the company’s playfulside in a session during the Spring2023 CMEpalooza event.

Here are the details (visit

• Wednesday, April 12, from 11AM-12PM EST

• Conundrums in CME: You Be the Jury

Andrea Funk, General Manager, Global Education Group

Melissa Wiles, President, Iridium Continuing Education

Carrie Roberts, CME Director, Steward Health Care

During this pro/con debate, the counsel will lay out their cases surrounding commoncontroversies in the continuing medical education field. Topics to be explored include desiredlevels of outcomes, learning styles controversies, and definition of a learner. After the debate,the audience will play the role of the juror and decide the outcome. The moderator (Judge) willsummarize the arguments to bring consensus and closure to the arguments.

The first “palooza” was held in the spring of 2014, and the organizers – Derek Warnick, acontinuing healthcare education professional and Scott Kober, MBA, CCMEP, Excalibur MedicalEducation – have turned it into a popular bi-annual gathering.

For more information, check out for the Spring 2022 CMEpalooza.

Melissa Wiles
Iridium Continuing Education

This press release can be viewed online at:

EINPresswire's priority is source transparency. We do not allow opaque clients, and our editorstry to be careful about weeding out false and misleading content. As a user, if you see somethingwe have missed, please do bring it to our attention. Your help is welcome. EIN Presswire,Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonablein today's world. Please see our Editorial Guidelines for more information.© 1995-2023 Newsmatics Inc. All Right Reserved.